Patent litigation with Wyeth in which Merck is seeking to revoke patents which cover Wyeth’s Prevnar 13 products (vaccines that reduce the incidence of severe ear infections in children, and pneumonia in the elderly). Wyeth has alleged infringement of these patents by the proposed launch of Merck’s own 15-valent vaccine.
The content of this publication is for reference purposes only. It is current at the date of publication. This content does not constitute legal advice and should not be relied upon as such. Legal advice about your specific circumstances should always be obtained before taking any action based on this publication.